Identification of <scp> <i>MAEL</i> </scp> as a promoter for the drug resistance model of <scp>iPSCs</scp> derived from <scp>T‐ALL</scp>-Reference-Cited by-同舟云学术

Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T‐ALL

Published:2022-04-29 Issue:18 Volume:11 Page:3479-3490
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Chen Xuemei¹²,Wen Feiqiu³,Li Zhu¹,Li Weiran¹²,Zhou Meiling¹,Sun Xizhuo¹,Zhao Pan⁴,Zou Chang⁴,Liu Tao¹^ORCID

Affiliation:

1. Department of Tumor Immunotherapy, Shenzhen Luohu People's Hospital The Third Affiliated Hospital of Shenzhen University Shenzhen Guangdong P.R. China

2. Medical Laboratory of Shenzhen Luohu People's Hospital Shenzhen China

3. Department of Hematology and Oncology Shenzhen Children's Hospital Shenzhen China

4. Department of Clinical Medical Research Center, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital) The First Affiliated Hospital of Southern University of Science and Technology Shenzhen Guangdong P.R. China

Funder

Shenzhen Graduate School, Peking University

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4712

Reference42 articles.

1. Epigenetics in T-cell acute lymphoblastic leukemia

2. The genetics and molecular biology of T-ALL

3. Combination effect of Notch1 and PI3K/AKT/mTOR signaling pathways inhibitors on T‐ALL cell lines;Khoshamooz H;Int J Hematol‐Oncol Stem Cell Res,2020

4. Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease

5. Regenerative therapy for vestibular disorders using human induced pluripotent stem cells (iPSCs): neural differentiation of human iPSC-derived neural stem cells after in vitro transplantation into mouse vestibular epithelia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy;Molecular Cancer;2023-11-28

2. Evaluation of the safety and efficiency of cytotoxic T cell therapy sensitized by tumor antigens original from T‐ALL‐iPSC in vivo;Cancer Innovation;2023-10-19